Source: European journal of haematology [Eur J Haematol] 2022 Jan; Vol. 108 (1), pp. 34-44. Date of Electronic Publication: 2021 Oct 11.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

Record details

Read Online Read More Add to Saved list

Academic Journal

Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics.

Authors : Richardson PG; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Schjesvold F

Source: European journal of haematology [Eur J Haematol] 2022 Jan; Vol. 108 (1), pp. 73-83. Date of Electronic Publication: 2021 Sep 22.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

Record details

Read Online Read More Add to Saved list

Academic Journal

Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.

Authors : Straka C; Medizinische Klinik, München Klinik Schwabing, Munich, Germany.; Salwender H

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Bortezomib/Bortezomib/Bortezomib/*administration & dosage ; Consolidation Chemotherapy/Consolidation Chemotherapy/Consolidation Chemotherapy/*methods

Source: European journal of haematology [Eur J Haematol] 2021 Nov; Vol. 107 (5), pp. 529-542. Date of Electronic Publication: 2021 Aug 28.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

Record details

Read Online Read More Add to Saved list

Academic Journal

Combinatorial treatment for unresectable unicentric Castleman disease.

Authors : Mohan M; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Meek JC

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Castleman Disease/Castleman Disease/Castleman Disease/*therapy ; Combined Modality Therapy/Combined Modality Therapy/Combined Modality Therapy/*methods

Source: European journal of haematology [Eur J Haematol] 2021 Oct; Vol. 107 (4), pp. 484-488. Date of Electronic Publication: 2021 Jul 18.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

Record details

Read Online Read More Add to Saved list

Editorial & Opinion

Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).

Authors : Renaud L; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.; Hemato-Oncology, Hôpital Saint-Louis, Paris, France.

Subjects: Adenine/Adenine/Adenine/*analogs & derivatives ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Central Nervous System Neoplasms/Central Nervous System Neoplasms/Central Nervous System Neoplasms/*drug therapy

Source: European journal of haematology [Eur J Haematol] 2021 Sep; Vol. 107 (3), pp. 370-373. Date of Electronic Publication: 2021 Jun 01.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

Record details

Read Online Read More Add to Saved list

Academic Journal

Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocol.

Authors : Morabito F; Biotechnology Research Unit, Aprigliano, Cosenza, Italy.; Department of Hematology and Bone Marrow Transplant Unit, Augusta Victoria Hospital, Jerusalem, Israel.

Subjects: Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/diagnosis ; Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy ; Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/metabolism

Source: European journal of haematology [Eur J Haematol] 2021 Jun; Vol. 106 (6), pp. 831-835. Date of Electronic Publication: 2021 Apr 07.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

Record details

Read Online Read More Add to Saved list

Academic Journal

Outcomes after intensive care unit admission in newly diagnosed diffuse large B-cell lymphoma patients: A real-life study.

Authors : Zduniak A; Department of Hematology, Centre Henri Becquerel, Rouen, France.; Mihailescu SD

Subjects: Hospital Mortality* ; Intensive Care Units* ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/diagnosis

Source: European journal of haematology [Eur J Haematol] 2021 Jun; Vol. 106 (6), pp. 788-799. Date of Electronic Publication: 2021 Mar 05.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

Record details

Read Online Read More Add to Saved list

Academic Journal

Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT.

Authors : Garderet L; Sorbonne Université, INSERM, UMR_S 938, Centre de Recherche Saint-Antoine- Team Proliferation and Differentiation of Stem Cells, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Service d'Hématologie, Paris, France.; Sbianchi G

Source: European journal of haematology [Eur J Haematol] 2021 May; Vol. 106 (5), pp. 708-715. Date of Electronic Publication: 2021 Feb 27.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

Record details

Read Online Read More Add to Saved list

Academic Journal

Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases.

Authors : Morabito F; Biothecnology Research Unit, AO of Cosenza, Cosenza, Italy.; Hematology and Bone Marrow Transplant Unit, Hemato-Oncology Department, Augusta Victoria Hospital, East Jerusalem, Israel.

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Leukemia, Lymphocytic, Chronic, B-Cell/Leukemia, Lymphocytic, Chronic, B-Cell/Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy; Adenine/Adenine/Adenine/administration & dosage

Source: European journal of haematology [Eur J Haematol] 2021 Apr; Vol. 106 (4), pp. 493-499. Date of Electronic Publication: 2021 Jan 28.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

Record details

Read Online Read More Add to Saved list

Academic Journal

Efficacy and tolerability of VCD chemotherapy in a UK real-world dataset of elderly transplant-ineligible newly diagnosed myeloma patients.

Authors : Rampotas A; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Oxford University Clinical Academic Graduate School, Oxford, UK.

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*drug therapy ; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*epidemiologyVCD protocol

Source: European journal of haematology [Eur J Haematol] 2021 Apr; Vol. 106 (4), pp. 563-573. Date of Electronic Publication: 2021 Feb 05.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

Record details

Read Online Read More Add to Saved list